Orgenesis Inc.
ORGS
CIK:
0001460602
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
20271 GOLDENROD LANE, GERMANTOWN, MD, 20876
Mailing Address
20271 GOLDENROD LANE, GERMANTOWN, MD, 20876
Phone
(480) 659-6404
Fiscal Year End
1231
EIN
980583166
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 13, 2026 | View on SEC |
| 8-K Current report of material events | January 26, 2026 | View on SEC |
| 8-K Current report of material events | September 16, 2025 | View on SEC |
| 8-K Current report of material events | August 25, 2025 | View on SEC |
| 8-K Current report of material events | August 19, 2025 | View on SEC |
| 8-K Current report of material events | August 1, 2025 | View on SEC |
| 8-K Current report of material events | June 6, 2025 | View on SEC |
| 8-K Current report of material events | April 22, 2025 | View on SEC |
Annual Reports
10-K
March 26, 2026
- Innovative 'Point-of-Care' platform decentralizes cell and gene therapy manufacturing.
- Strategic shift toward cost-cutting and asset divestiture to stabilize operations.
Material Events
8-K
Leadership Change
March 13, 2026
High Impact
- Appointment of new CFO and two independent directors to strengthen leadership.
- Proactive effort to address operational and market challenges, including OTC Expert Market status.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.